GBR 12909 Study in Cocaine Experienced African American Volunteers - 1

National Institute on Drug Abuse (NIDA)10 enrolled

Overview

The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.

Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. Particular interest is being given to the hematological safety data.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Enrollment

Conditions

Cocaine-Related Disorders

Interventions

GBR 12909DRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Must be within 20% of ideal body weight and must weigh at least 45 kg. * Must understand the study procedures and provide written informed consent. * Must meet DSM-4 criteria for abuse or dependence on cocaine. * Must be non-treatment seeking at the time of the study. Exclusion Criteria: * Please contact the study site for more information.

Locations (1)

Uniformed Services University of Health Science

Bethesda, Maryland, United States

Outcomes

Primary Outcomes

pharmacokinetic assessment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.